M.L. Dubbelaar

Type de document

Co-auteur

E.M. Wolfschmitt

J. Walz

D.E. Speiser

H.G. Rammensee

M.T. Purde

O.T. Pop

R. Niederer

J. Neefjes

A. Marcu

J.J. Luimstra

B. Ludewig

T. Lenz

M. Jörger

W. Jochum

A.K. Jochum

O. Hasan Ali

S. Haen

T. Gross

M. Früh

L.K. Freudenmann

L. Flatz

C. Driessen

A. Cozzio

C. Cicin-Sain

D. Bomze

F. Berner

P. Baumgaertner

J. Bauer

C. Appenzeller

M.T. Abdou

Date

Source

Serveur académique Lausannois (1)

Mot-clé

toxicité (1) thérapie (1) différenciation (1) survie (1) Differentiation (1) Development (1) Treatment (1) Inhibitors (1) Identification (1) Antigenic determinants (1) Vaccination (1) Tumors (1) Therapeutics (1) T cells (1) Survival (1) Proteins (1) Patients (1) Human beings (1) Lungs--Cancer (1) Lungs (1) Keratinocytes (1) Identification (1) Comprehension (1) Cells (1) Cancer (1) Antigens (1) Identification (1) Toxicology (1) Vaccination (1) Use (1)

Documents écrit par M.L. Dubbelaar (1) | parle de M.L. Dubbelaar (0)

Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.

F. Berner et al. (2021)